跳至主要内容
临床试验/NCT05912647
NCT05912647招募中不适用

A Multiphase Optimization Strategy to Enhance Diabetes Management Interventions for Patients With Uncontrolled Diabetes

University of Wisconsin, Madison1 个研究点 分布在 1 个国家目标入组 376 人开始时间: 2024年2月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
376
试验地点
1
主要终点
Change in mean hemoglobin A1c score

研究概览

简要总结

The purpose of the study is to learn about the best way to enhance pharmacy-related care for diabetes self-management.

This research is being done because we want to improve use of medicines and diabetes management among adults with type 2 diabetes and find out which of type of support may improve diabetes self-management for adults.

Participants will be assigned to one of 4 groups, and will either:

  • receive care as usual; or,
  • receive added medicine management support from a pharmacist; or,
  • receive support from a Community Health Worker (CHW) to address life challenges; or,
  • receive both the pharmacist medicine management and the CHW support

详细描述

For the ENRxICH intervention, all participants will receive usual care for their diabetes management. Participants will be randomized to one of four treatment conditions: 1. Usual Care, 2. Medication Therapy Management (MTM) Optimizing Medication Therapy (ON), 3. Community Health Worker (CHW) addressing social determinants of health (SDOH) and diabetes and medicine misperceptions (ON), or 4. both MTM Optimizing Medication Therapy and CHW Addressing SDOH and diabetes and medicine misperceptions for 6 months.

Subjects randomized to the treatment conditions including MTM will receive a minimum of five pharmacist-delivered Medication Therapy Management (MTM) sessions with a pharmacist, two in the first month, one medication review each in the second and third month, and a final medication review at 6 months.

Subjects randomized to the treatment conditions including CHW support addressing social determinants of health (SDOH) which will involve meeting with the CHW for a formal, standardized 2-hour assessment of five common SDOH barriers related to diabetes management, (1) food insecurity, (2) transportation, (3) prescription medication assistance, (4) access to diabetes education, and (5) physical activity resources (See Table 6). After the initial session at the participant's home (or another community location), the participant will have the option of continuing to work with the CHW to address barriers for the intervention duration. CHW support will also address diabetes and medicine misperceptions by completing a series of phone calls with the subject to provide information about managing diabetes and medicines, discuss cultural health misperceptions, share medication adherence experiences, and provide social support over the phone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women ages 18-90 with diagnosed type 2 diabetes who speak and understand English or Spanish.
  • Taking at least one oral or injectable diabetes medication
  • HbA1c ≥ 7.5% based on point of care test.
  • Will reside in the geographical area throughout the study period.
  • Have access to a phone during the study period.
  • Willing to attend all orientation/training sessions.

排除标准

  • Having a caregiver who is the main decision maker in self-management.
  • Participating in another lifestyle, or medication adherence program.
  • Participated in standard MTM/MTM-related intervention in the last 6 months.
  • Women who are pregnant or plan to get pregnant in the next 6 months.

研究组 & 干预措施

MTM + CHW

Experimental

干预措施: CHW (Behavioral)

Usual Care

No Intervention

Medication Therapy Management (MTM)

Experimental

干预措施: MTM (Behavioral)

Community Health Worker (CHW)

Experimental

干预措施: CHW (Behavioral)

MTM + CHW

Experimental

干预措施: MTM (Behavioral)

结局指标

主要结局

Change in mean hemoglobin A1c score

时间窗: Baseline to 12 months

HbA1c will be measured, and the mean change will be compared across arms

Change in mean hemoglobin A1c score

时间窗: Baseline to 6 months

HbA1c will be measured, and the mean change will be compared across arms

次要结局

  • Change in medication adherence - medication refill(6 months and 12 months)
  • Mean scores on the Adherence to Refills and Medications Scale for Diabetes(6 months and 12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Enhancing Diabetes Management Approaches for... | 临床试验